Evaluation of fluocinolone acetonide sustained release implant (retisert) dissociation during implant removal and exchange surgery

American Journal of Ophthalmology

Volumn 154, Issue 6, 2012, Pages

  Nicholson, Benjamin P ^a   Singh, Rishi P ^a   Sears, Jonathan E ^a   Lowder, Careen Y ^a   Kaiser, Peter K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOCINOLONE ACETONIDE;

ADULT; ARTICLE; CHOROID HEMORRHAGE; CLINICAL ARTICLE; DEVICE REMOVAL; EVALUATION; HUMAN; INTRAVITREAL IMPLANT; OBSERVATIONAL STUDY; PEROPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REIMPLANTATION; RETINA TEAR; RETROSPECTIVE STUDY; SUSTAINED DRUG RELEASE; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 84869088906     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2012.06.004     Document Type: Article

References (15)

1. D.G. Callanan, G.J. Jaffe, D.F. Martin, P.A. Pearson, T.L. Comstock Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results Arch Ophthalmol 126 9 2008 1191 1201
2. G.J. Jaffe, D. Martin, D. Callanan, P.A. Pearson, B. Levy, T. Comstock Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study Ophthalmology 113 6 2006 1020 1027 (Pubitemid 43795240)
3. M. Taban, C.Y. Lowder, P.K. Kaiser Outcome of fluocinolone acetonide implant (Retisert) reimplantation for chronic noninfectious posterior uveitis Retina 28 9 2008 1280 1288
4. G.J. Jaffe Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis Am J Ophthalmol 145 4 2008 667 675
5. S. Yeh, C.M. Cebulla, S.R. Witherspoon Management of fluocinolone implant dissociation during implant exchange Arch Ophthalmol 127 9 2009 1218 1221
6. W. Wan, J.M. Stewart Use of a high infusion rate to prevent posterior dislocation of fluocinolone acetonide implant during surgical removal Ocul Immunol Inflamm 19 3 2011 214 215
7. G.J. Jaffe, J. Ben-Nun, H. Guo, J.P. Dunn, P. Ashton Fluocinolone acetonide sustained drug delivery device to treat severe uveitis Ophthalmology 107 11 2000 2024 2033
8. C. Pavesio, M. Zierhut, K. Bairi, T.L. Comstock, D.W. Usner Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis Ophthalmology 117 3 2010 567 575 e561
9. C.B. Hebson, S.K. Srivastava A functional, nonfunctioning Retisert implant Ocul Immunol Inflamm 19 3 2011 210 211
10. A. Galor, R. Margolis, P.K. Kaiser, C.Y. Lowder Vitreous band formation and the sustained-release, intravitreal fluocinolone (Retisert) implant Arch Ophthalmol 125 6 2007 836 838 (Pubitemid 46919749)
11. R.L. Ufret-Vincenty, R.P. Singh, C.Y. Lowder, P.K. Kaiser Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant Am J Ophthalmol 143 2 2007 334 335 (Pubitemid 46136145)
12. J.L. Sims, S.p. Chee Cytomegalovirus endotheliitis following fluocinolone acetonide (Retisert) implant Eye (Lond) 24 1 2010 197 198
13. K.J. Ramaiya, P.K. Rao Herpetic necrotizing retinitis following fluocinolone acetonide intravitreal implant Ocul Immunol Inflamm 19 1 2011 72 74
14. M. Boulton, Z. Gregor, D. McLeod Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management Br J Ophthalmol 81 3 1997 228 233 (Pubitemid 27120890)
15. Bausch & Lomb I Retisert Prescribing Information Sheet. June 2009 2009 Bausch & Lomb Rochester, NY